Avicanna Inc. AVCNF
0.08 USD 0.00 (+1.33%)
At closeNov 9, 2026, 4:00 PM EST
0.0796 Day range 0.0796
0.06 52-week range 0.195
- YTD
- -53.09%
- 1 year
- -57.30%
News
globenewswire.com Avicanna to Report Q3 2026 Results and Host Call on Nov. 12 TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and…
globenewswire.com Avicanna Announces Closing of Non-Brokered Private Placement of Non-Convertible Debenture Units NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES…
globenewswire.com Avicanna Transitions US Listing to OTCQB TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQB: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and…
globenewswire.com Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026 TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”), a commercial-stage international biopharmaceutical company focused on cannabinoid-based medicines, is pleased…
defenseworld.net Short Interest in Avicanna Inc. (OTCMKTS:AVCNF) Rises By ∞ Avicanna Inc. (OTCMKTS:AVCNF - Get Free Report) was the target of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 38,879 shares, a…
globenewswire.com Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada Integrating MyMedi.ca healthcare provider-guided medical cannabis care into hospitals, specialty clinics, insurers and multidisciplinary healthcare networks in Canada Integrating MyMedi.ca healthcare…
globenewswire.com Avicanna Announces Closing of Strategic Non-Brokered Private Placement Strategic investment by pharmaceutical executive and life sciences investor Michael Porter Strategic investment by pharmaceutical executive and life sciences investor Michael Porter
globenewswire.com Avicanna Reports Q2 2026 Financial Results Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product sales QUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured
globenewswire.com Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio Initial Medical Cannabis SKUs, Including Rapid-Onset Capsules and Soft Chews, Planned for Q3 2026 Improving Patient Access with Accurately Dosed, Rapid-Onset and Non-Combustible Formats
globenewswire.com Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and…
globenewswire.com Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare FORT LAUDERDALE, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) today announced the completion of a CDN$300,000 strategic investment in Avicanna Inc. (TSX:…
globenewswire.com Avicanna Announces Closing of Non-Brokered Private Placement NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES…
globenewswire.com Avicanna Reports Q1 2026 Financial Statements Record revenue and gross profits driven by Canadian commercial growth and proprietary product expansion Continued advancement of pharmaceutical pipeline, medical affairs initiatives and international…
seekingalpha.com Avicanna Inc. (AVCN:CA) Shareholder/Analyst Call Prepared Remarks Transcript Avicanna Inc. (AVCN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
globenewswire.com Avicanna Announces Results of Annual General and Special Meeting TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and…
globenewswire.com Avicanna Announces Change in Board of Directors TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and…
globenewswire.com Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update Rescheduling aligns with Avicanna's established pharmaceutical and medical cannabis strategyRescheduling further supports advancement of R&D, clinical development, and medical affairs initiatives
globenewswire.com Annual General and Special Meeting of Shareholders to be held May 7, 2026 TORONTO, April 21, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and…
globenewswire.com ThreeD Capital Inc. Issues Early Warning Report in Connection with Disposition of Securities of Avicanna Inc. TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the…
benzinga.com Cannabis Stock Gainers And Losers From August 16, 2023 GAINERS: Red White & Bloom Brands (OTC: RWBYF) shares closed up 300.00% at $0.04
benzinga.com Stocks That Hit 52-Week Lows On Thursday 
benzinga.com Stocks That Hit 52-Week Highs On Wednesday